Soleil Securities Upgrades Accuray (ARAY) to Buy; Compelling Acquisition of TomoTherapy
Tweet Send to a Friend
Soleil Securities upgraded Accuray (NASDAQ: ARAY) from Sell to Buy.
Soleil analyst says, "We're raising our ARAY recommendation to BUY ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Soleil analyst says, "We're raising our ARAY recommendation to BUY ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
